BIPHASIX
Trademark domain | |
name | is free? |
---|---|
biphasix.com |
The "BIPHASIX" trademark, serial number 75546684 , was filed on 2nd of September 1998 with a mark drawing code of 1000 and its transaction date is 75546684. The attorney assigned is G L Pinchak, attorney docket number 4741. Since 31st of December 2009, the document can be found in the M60 law office in the publication and issue section. The employee responsible is BHATTI, FARAH P and the date it was published for opposition on 08/29/2000. The status of the trademark was checked last on 11/22/2003.
Other trademarks by this attorney include , INGREDIENTS MATTER . The corresponded responsible for this trademark is G L PINCHAK, located at WATTS HOFFMANN FISHER & HEINKE CO LPA, 1100 SUPERIOR AVE E STE 1750, CLEVELAND OH 44114-2544.The state or country where the trademark was organized is by Pharmaderm Laboratories Ltd.. The legal entity type behing it is a Corporation, located at 3 - 411 Downey Road, Saskatoon, zip S7N 4L8.
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 10/08/1998 |
Primary Code | 005 |
Goods codes | |
GS0051 | DERMAL AND MUCOSAL DRUG DELIVERY SYSTEMS COMPRISED OF LIQUIDS, CREAMS AND GELS APPLIED TO THE SKIN OR MUCOSA AND CONTAINING PHARMACEUTICAL AGENTS ENCAPSULATED IN VESICLES UTILIZING A LIPID-BASED MICROENCAPSULATING PROCESS, FOR USE IN THE TREATMENT OF CARDIOLOGICAL DISEASES, DERMATOLOGICAL DISEASES, ENDOCRINE DISORDERS, GASTROINTESTINAL DISORDERS, HEMATOLOGICAL DISORDERS, BACTERIAL INFECTIOUS DISEASES, FUNGAL INFECTIOUS DISEASES, PARASITIC INFECTIOUS DISEASES, VIRAL INFECTIOUS DISEASES, MALIGNANT CANCER DISORDERS, METABOLIC DISEASES, NEUROLOGICAL DISORDERS, OPHTHALMOLOGY, DISORDERS, POISONING DISORDERS PSYCHIATRIC DISORDERS, PULMONARY DISORDERS, RENAL DISORDERS, RHEUMATOLOGICAL DISORDERS, NAUSEA, DIARRHEA, LOCAL PAIN, SYSTEMIC PAIN, OBESITY, ERECTILE DYSFUNCTION, SARCOIDOSIS, SLEEP DISORDERS AND PROVIDING VACCINE TREATMENTS |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
10/20/1999 | FINAL REFUSAL MAILED | O - Outgoing Correspondence | CNFR - FINAL REFUSAL MAILED | |
12/30/2003 | ABANDONMENT - NO USE STATEMENT FILED | S | ABN6 - ABANDONMENT - NO USE STATEMENT FILED | |
06/17/2003 | EXTENSION 5 GRANTED | S | EX5G - EXTENSION 5 GRANTED | |
05/21/2003 | EXTENSION 5 FILED | S | EXT5 - EXTENSION 5 FILED | |
05/21/2003 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
01/23/2003 | EXTENSION 4 GRANTED | S | EX4G - EXTENSION 4 GRANTED | |
11/13/2002 | EXTENSION 4 FILED | S | EXT4 - EXTENSION 4 FILED | |
11/15/2002 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
05/22/2002 | EXTENSION 3 GRANTED | S | EX3G - EXTENSION 3 GRANTED | |
05/10/2002 | EXTENSION 3 FILED | S | EXT3 - EXTENSION 3 FILED | |
05/13/2002 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
12/10/2001 | EXTENSION 2 GRANTED | S | EX2G - EXTENSION 2 GRANTED | |
11/20/2001 | EXTENSION 2 FILED | S | EXT2 - EXTENSION 2 FILED | |
05/24/2001 | EXTENSION 1 GRANTED | S | EX1G - EXTENSION 1 GRANTED | |
05/11/2001 | EXTENSION 1 FILED | S | EXT1 - EXTENSION 1 FILED | |
11/21/2000 | NOA MAILED - SOU REQUIRED FROM APPLICANT | O - Outgoing Correspondence | NOAM - NOTICE OF ALLOWANCE-MAILED | |
08/29/2000 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
07/28/2000 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
04/21/2000 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
02/14/2000 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
08/16/1999 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
04/30/1999 | NON-FINAL ACTION MAILED | F - First Action | CNRT - NON-FINAL ACTION MAILED | |
04/13/1999 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER |
The "BIPHASIX" trademark, serial number 78336585 , was filed on 4th of December 2003 with a mark drawing code of 4000 and its transaction date is 78336585. The attorney assigned is George L. Pinchak, attorney docket number 4741/14-825I. Since 31st of December 2009, the document can be found in the M60 law office in the publication and issue section. The status of the trademark was checked last on 10/12/2005.
Other trademarks by this attorney include , EXTREMELINE , INGREDIENTS MATTER . The corresponded responsible for this trademark is George L. Pinchak, located at Watts Hoffmann Co., LPA, Watts Hoffmann Co., LPA Suite 1750 1100, Cleveland, OH 44114-2518.The state or country where the trademark was organized is by Pharmaderm Laboratories Ltd.. The legal entity type behing it is a Corporation, located at 3-411 Downey Road, Saskatoon, zip S7N 4L8.
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 12/30/2003 |
Primary Code | 005 |
Goods codes | |
GS0051 | DERMAL AND MUCOSAL DRUG DELIVERY LIQUIDS, CREAMS AND GELS APPLIED TO THE SKIN OR MUCOSA AND CONTAINING PHARMACEUTICAL AGENTS ENCAPSULATED IN VESICLES UTILIZING A LIPID-BASED MICROENCAPSULATING PROCESS, FOR USE IN THE TREATMENT OF DERMATOLOGICAL DISEASES, BACTERIAL INFECTIOUS DISEASES, FUNGAL INFECTIOUS DISEASES, PARASITIC INFECTIOUS DISEASES, VIRAL INFECTIOUS DISEASES, MALIGNANT CANCER DISORDERS, LOCAL PAIN, ERECTTLE DISFUNCTION, AND PROVIDING VACCINE TREATMENTS |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
10/12/2005 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | O - Outgoing Correspondence | MAB2 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | |
10/12/2005 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | O - Outgoing Correspondence | ABN2 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | |
03/12/2005 | NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRT - NON-FINAL ACTION E-MAILED | |
03/12/2005 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
02/04/2005 | AMENDMENT FROM APPLICANT ENTERED | I - Incoming Correspondence | ACEC - AMENDMENT FROM APPLICANT ENTERED | |
01/11/2005 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
01/11/2005 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
07/09/2004 | NON-FINAL ACTION MAILED | F - First Action | CNRT - NON-FINAL ACTION MAILED | |
07/03/2004 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
12/30/2003 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.